CCR5 Up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with CCR5 Up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with CCR5 Up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with CCR5 Up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with CCR5 Up.

Results found

Linked to

 

Label

Description

 

Gene

ENSG00000100983 - glutathione synthetase

Gene

ENSG00000006712 - PAF1 component of Paf1/RNA polymerase II complex

Gene

ENSG00000161381 - plexin domain containing 1

Gene

ENSG00000136630 - H2.0 like homeobox

Gene

ENSG00000105483 - caspase recruitment domain family member 8

Gene

ENSG00000141759 - thioredoxin like 4A

Gene

ENSG00000120458 - Myb/SANT DNA binding domain containing 2

Gene

ENSG00000064999 - ankyrin repeat and sterile alpha motif domain containing 1A

  • Gene

    ENSG00000100983 - glutathione synthetase


  • Gene

    ENSG00000006712 - PAF1 component of Paf1/RNA polymerase II complex


  • Gene

    ENSG00000161381 - plexin domain containing 1


  • Gene

    ENSG00000136630 - H2.0 like homeobox


  • Gene

    ENSG00000105483 - caspase recruitment domain family member 8


  • Gene

    ENSG00000141759 - thioredoxin like 4A


  • Gene

    ENSG00000120458 - Myb/SANT DNA binding domain containing 2


  • Gene

    ENSG00000064999 - ankyrin repeat and sterile alpha motif domain containing 1A

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.